Gts Securities LLC Acadia Pharmaceuticals Inc Call Options Transaction History

Gts Securities LLC

  • $46.5 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
BUY
$17.79 - $30.86 $503,457 - $873,338
28,300 Added 61.39%
74,400 $1.38 Million
Q4 2023

Feb 14, 2024
BUY
$20.78 - $31.77 $135,070 - $206,505
6,500 Added 16.41%
46,100 $1.44 Million
Q3 2023

Nov 15, 2023
BUY
$20.84 - $33.47 $825,264 - $1.33 Million
39,600 New
39,600 $825,000

Others Institutions Holding ACAD

# of Institutions
288
Shares Held
161M
Call Options Held
723K
Put Options Held
257K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.54B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email